How Focused Eye Care Manages Myopia
The goal of myopia management is slow down, or even halt, the progression of your child’s myopia. Focused Eye Care uses FDA approved and well-researched technologies.
The important thing to note is that your child’s nearsightedness does NOT need to progress year after year. Our team can diagnose your child’s vision and determine an appropriate management plan. Learn more below.
MiSight® 1 Day Contact Lenses
MiSight® 1 day contact lenses are the first and only FDA-approved* soft daily contact lenses to slow the progression of myopia in children aged 8-12 at the initiation of treatment. Click here to learn more about MiSight® 1 day contact lenses!
Orthokeratology lenses are a non-surgical option that temporarily corrects myopia so that no glasses or contact lenses are needed during the day. Orthokeratology lenses are worn overnight and reshape the cornea while sleeping to provide clear vision after removal. These lenses are have been shown to be safe and effective in slowing the progression of myopia in clinical trials such as the SMART study.
Learn more about Orthokeratology at Focused Eye Care.
Low-dose atropine eye drops
Atropine is an eye drop that causes the pupil to dilate. It is FDA approved for office use at 1%. Studies such as the LAMP study have shown evidence supporting the use of low concentrations of atropine to slow the progression of myopia. Low dose atropine of 0.025% slowed eye growth by about 30% and 0.05% by about 50% in the LAMP study. Side effects of low-dose atropine can include blurry vision up close and light sensitivity, but the LAMP study showed that these symptoms were well tolerated by the participants.
Together, we can stay at the forefront of myopia. Schedule an appointment with Dr. McHugh to discuss your options today!